Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients

NCT03231371 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Orthotopic Heart Transplant

Interventions

DRUG: Adenosine

Sponsor

Bryan Goldstein